MYRTIS LOUDERMILK: Open Payments
NPI 1245019355 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,208 in 89 payments from 16 companies in 2025. Trend: 2023 $240 · 2024 $1,186 · 2025 $2,208
Food & beverage: $2,208
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $606 |
| Axsome Therapeutics, Inc. | 21 | $482 |
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $182 |
| Amgen Inc. | 4 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $105 |
| Lilly USA, LLC | 5 | $97 |
| Radius Health, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
Products named: Auvelity, Wegovy, EVENITY, Ozempic, CAPLYTA, Kerendia, AIRSUPRA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
